Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001641172-25-013465
Filing Date
2025-06-03
Accepted
2025-06-03 16:30:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11319
2 EX-99 ex99.htm EX-99 10843
  Complete submission text file 0001641172-25-013465.txt   23870
Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Subject) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94832 | Film No.: 251020067
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1200 MORRIS TURNPIKE, SUITE 3005 SHORT HILLS NJ 07078
Business Address 1200 MORRIS TURNPIKE, SUITE 3005 SHORT HILLS NJ 07078 (617) 880-4598
Validae Health, L.P. (Filed by) CIK: 0002051634 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G